CompletedPhase 2NCT01448213

Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)

Studying Corneal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Price Vision Group
Principal Investigator
Francis W Price, MD, M.D
Price Vision Group
Intervention
Prednisolone acetate(drug)
Enrollment
264 enrolled
Eligibility
18 years · All sexes
Timeline
20112014

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01448213 on ClinicalTrials.gov

Other trials for Corneal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Corneal dystrophy

← Back to all trials